OnKure Therapeutics, Inc. (OKUR) Institutional Ownership Changes & 13F Activity
OnKure Therapeutics, Inc. (OKUR). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Trails Edge Capital Partners, Lp, Bvf Inc/Il, Prosight Management, Lp, Citadel Advisors Llc, and Logos Global Management Lp.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Citadel Advisors Llc | Buy | +1,149,460 | +3058.1% | 1,187,047 | $5.41M | Q2 2026 | Sep 02, 2026 |
| Cantor Fitzgerald, L. P. | Buy | +114 | +0.1% | 100,014 | $456.06K | Q2 2026 | Aug 19, 2026 |
| Seven Fleet Capital Management Lp | Buy | +240,963 | — | 240,963 | $1.10M | Q2 2026 | Aug 17, 2026 |
| Stonepine Capital Management, Llc | Sell | -1,894 | -1.4% | 130,684 | $595.92K | Q2 2026 | Aug 17, 2026 |
| Trails Edge Capital Partners, Lp | Buy | +1,438,456 | — | 1,438,456 | $6.56M | Q2 2026 | Aug 14, 2026 |
| Bvf Inc/Il | Buy | +1,256,806 | +63.5% | 3,235,778 | $14.76M | Q2 2026 | Aug 14, 2026 |
| Prosight Management, Lp | Sell | -1,175,389 | -54.6% | 978,992 | $4.46M | Q2 2026 | Aug 14, 2026 |
| Logos Global Management Lp | Buy | +963,855 | — | 963,855 | $4.40M | Q2 2026 | Aug 14, 2026 |
| Ensign Peak Advisors, Inc | Buy | +431,631 | — | 431,631 | $1.97M | Q2 2026 | Aug 14, 2026 |
| Rosalind Advisors, Inc. | Sell | -293,763 | -66.2% | 150,000 | $684.00K | Q2 2026 | Aug 14, 2026 |
| Adar1 Capital Management, Llc | Sell | -196,257 | -8.1% | 2,238,684 | $10.21M | Q2 2026 | Aug 14, 2026 |
| Sofinnova Investments, Inc. | Buy | +179,992 | +127.0% | 321,692 | $1.47M | Q2 2026 | Aug 14, 2026 |
| Longaeva Partners L.P. | Buy | +120,482 | — | 120,482 | $549.40K | Q2 2026 | Aug 14, 2026 |
| Bank Of America Corp | Buy | +106,320 | — | 106,320 | $484.82K | Q2 2026 | Aug 14, 2026 |
| Two Sigma Investments, Lp | Buy | +84,608 | +348.7% | 108,870 | $496.45K | Q2 2026 | Aug 14, 2026 |
| Shay Capital Llc | Sell | -82,219 | -62.2% | 50,000 | $228.00K | Q2 2026 | Aug 14, 2026 |
| Charles Schwab Investment Management Inc | Buy | +63,640 | — | 63,640 | $290.20K | Q2 2026 | Aug 14, 2026 |
| Prelude Capital Management, Llc | Buy | +46,692 | — | 46,692 | $212.92K | Q2 2026 | Aug 14, 2026 |
| Bridgeway Capital Management, Llc | Buy | +34,000 | +208.7% | 50,293 | $229.34K | Q2 2026 | Aug 14, 2026 |
| Verdad Advisers, Lp | Buy | +28,660 | — | 28,660 | $130.69K | Q2 2026 | Aug 14, 2026 |
| Wells Fargo & Company/Mn | Buy | +22,951 | +170.0% | 36,451 | $166.22K | Q2 2026 | Aug 14, 2026 |
| Price T Rowe Associates Inc | Buy | +21,481 | — | 21,481 | $98.00K | Q2 2026 | Aug 14, 2026 |
| Xtx Topco Ltd | Sell | -17,159 | -50.3% | 16,970 | $77.38K | Q2 2026 | Aug 14, 2026 |
| T. Rowe Price Investment Management, Inc. | Buy | +15,335 | — | 15,335 | $70.00K | Q2 2026 | Aug 14, 2026 |
| Vestal Point Capital, Lp | Sell | -14,120 | -0.8% | 1,825,699 | $8.33M | Q2 2026 | Aug 14, 2026 |
| Invesco Ltd. | Buy | +13,636 | — | 13,636 | $62.18K | Q2 2026 | Aug 14, 2026 |
| Mirae Asset Global Etfs Holdings Ltd. | Buy | +12,069 | — | 12,069 | $55.03K | Q2 2026 | Aug 14, 2026 |
| Barclays Plc | Buy | +6,720 | +26.9% | 31,720 | $144.64K | Q2 2026 | Aug 14, 2026 |
| Legal & General Group Plc | Buy | +2,555 | — | 2,555 | $11.65K | Q2 2026 | Aug 14, 2026 |
| Royal Bank Of Canada | Buy | +737 | +320.4% | 967 | $4.00K | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about OKUR activity
Which institutional owners are buying OKUR?
Institutional owners buying OKUR include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in OKUR activity?
"Buy" means an investor increased their reported position in OKUR compared to the prior reporting period. This reflects growing exposure to OnKure Therapeutics, Inc. (OKUR) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in OKUR increasing?
Institutional interest in OKUR can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.